To me a stimulating suggestion regarding cancer is that most of us in our life develop neoplasia in some organ or another but that usually we reject the neoplastic cells, possibly by a mechanism similar to that of graft rejection.
Since choriocarcinomata are derived from foetal tissue, one of the chromosomes in each chromosome pair in the tumour is paternal in origin and the growth must therefore be considered a partially allogeneic graft. This might have some relation to the progress or halting of the disease (see Clarke 1962) which, as is well known, runs an extremely unpredictable course. A priori, it would seem reasonable that where the mother and the cancer had similar histocompatibility genes the disease would take a more sinister course and, conversely, where the cancer was incompatible it might be kept in check or rejected. There is some support for these views. Scott (1962 Scott ( , 1968 found that the maternal ABO blood group distribution showed a shift away from 0 to A, B and AB which was in keeping with the idea that foetomaternal compatibility is an aetiological factor. Ben-Hur et al. (1965) found that in 3 patients with choriocarcinoma skin homografts from the husband were accepted, whereas those from other donors were rejected. The authors suggest that since some hydatidiform moles undergo transformation to choriocarcinomata every woman with a mole should be grafted with her husband's skin. Where this homograft is not rejected they advise against further pregnancies (presumably for about two years) since the risk of development of choriocarcinoma would be high and pregnancy would confuse the diagnosis. Mogensen & Kissmeyer-Nielsen (1967 ) carried out family studies on choriocarcinoma cases in order to establish whether the matings could produce zygotes which were histocompatible with the mothers, the antigens investigated being the important histocompatibility antigens, i.e. the ABO and those at the HLA locus. While the investigation is still in a preliminary state, the authors are so far impressed by the high degree of histocompatibility observed.
There is about a 500% chance of any donor and recipient being compatible or incompatible for the major histocompatibility genes, so this might mean that in 50 % of those cases where the mole becomes malignant the malignancy would be checked.
Further support for the view that immunity is important in cancer comes from the fact that patients with renal transplants appear prone to certain forms of cancer (lymphoma and lymphosarcoma), presumably due to prolonged immunosuppressive therapy.
Prezygotic Selection against Certain Types ofSpermatozoa It is generally agreed that when there is incompatibility between mother and foetus on the ABO system there is more chance than usual of abortion, but what I want to discuss now is differential elimination of spermatozoa by reason of blood group incompatibility before there is any question of a zygote being formed. For example, there is evidence which suggests that sperms carrying the A or B blood group genes tend to be eliminated because they are serologically incompatible with the anti-A or anti-B antibody found in the cervical secretions of the mother. There has been a good deal of argument as to whether this particular differential elimination really takes place, but Ackerman (1967) showed clearly that the metabolism of human spermatozoa was different in spermatozoa of different ABO blood type and secretor status. Thus when group A and group B 'secretor' spermatozoa were incubated in vitro with immune anti-A or anti-B, glycolysis was reduced and respiration increased, though no effect was produced by sera containing naturally occurring anti-A or anti-B. If this happens in vivo it would mean that any infertility due to this cause would tend to occur after several babies since immune anti-A and anti-B usually develop following maternal immunization by the transplacental passage of foetal cells. Nevertheless, people occasionally have immune anti-A or anti-B for no obvious reason and it would be worth testing for these particular antibodies when no obvious cause for infertility is found. have no particular knowledge of these disorders, but good accounts may be found in Mollison (1967 ), Gell & Coombs (1963 and Levene & Rosenfeld (1961) . A few of the important features in each are: 1214 Proc. roy. Soc. Med. Volume 61 November 1968 ABO heemolytic disease: This is not usually as severe as the Rh form and first babies are often affected (cf. Rh). It is almost entirely confined to group 0 mothers, and the incompatible foetus is nearly always a secretor of its blood group. The himolysis is due to 'immune' not to naturally occurring anti-A and anti-B, but there are often difficulties in distinguishing between the two and some people have the immune form of antibody without any obvious previous stimulus. ABO incompatibility as between mother and foetus is protective against Rh immunization, the naturally occurring anti-A and anti-B 'destroying' the Rh-positive foetal red cells before they have time to immunize. Keil hwmolytic disease: Ninety per cent of all people are Kell-negative and for this reason the disease is rare, but it can be lethal. The initial stimulus is often a blood transfusion rather than a Kell-positive pregnancy.
Other blood group incompatibilities: HDN has been reported due to incompatibility in the Kidd system, to anti-S, to anti-s and to anti-M, but not so far to anti-N. There are also well documented cases due to Diego, Duffy, Lutheran and Lewis incompatibility, and in fact no antigen, frequent or rare, seems to be unable to cause HDN (Gell & Coombs 1963) .
Rh Hamolytic Disease and its Prevention
The work which has led to a promising method of preventing Rh iso-immunization is well known (British Medical Journal 1966 , Clarke 1967 . Table 1 The idea was simply to mimic the protection afforded by ABO incompatibility between mother and foetus by giving, within forty-eight hours of delivery, anti-Rh antibody in the much more frequent situation where the Rh-negative mother and the Rh-positive foetus are compatible on the ABO system. The latest figures in various trials are shown in Tables 1 and 2. Despite the very successful prophylaxis, a number of problems remain and I will mention four:
(1) The mechanism ofprotection: This is uncertain but puts forward two main possibilities, and I quote from his leader: 'The first is that passively administered antibody causes the phagocytosis and destruction of antigen before it can come into contact with antibodyforming cells; one piece of evidence seems to be much against this possibility: if two antigenic determinants on a single molecule are injected, together with an antibody against only one of the antigenic determinants, antibody formation against this determinant only is suppressed and the animal forms antibody against the second antigen (Brody, Walker and Siskind, 1967) . The second possibility is that passively administered antibody combines with antigen (probably after it has been "processed" by macrophages) and prevents it from combining with receptors of the same specificity on particular antibody-forming cells. One piece of evidence which is much in favour of this ...
[is] that there appears to be a relation between the binding constant of an antibody and its ability to suppress primary immunization.
'If it is true that passively administered antibody suppresses primary immunization by binding antigen rather than by destroying it, then the mere clearance Combined data from various centres, giving results after six months and later in controls and in women injected with anti-D y-globulin of Rh-positive red cells from the circulation may not suffice to prevent immunization. For example, the injection of a few micrograms of anti-Rh may be sufficient to bring about the accelerated clearance of 0 3 ml. of Rh-positive red cells but under these conditions less than 1 per cent of the antibody is bound to antigen (Mollison and Hughes-Jones, 1967) , and primary immunization is not always prevented (unpublished observations).'
(2) Dosage: In most of the trials that have been reported, the minimum dose has been of the order of 200 ,±g of anti-D gammaglobulin, and judging by some work of Pollack et al. (1967) (see Table 3 ) this is probably enough for nearly all cases. Nevertheless, with really big transplacental haemorrhages the correct dosage is not yet known, and several failures have been reported, those of the Dutch cases suggesting that enhancement may even have occurred (Table 4 ).
(3) Problem ofprimed or 'sensibilized' individuals:
In some of the trials multipart without demonstrable antibodies have been included, and the question is whether primed cases ever get into these trials. It may be that they never do since it can be argued that a second Rh-positive pregnancy will always make an occult antibody become overt. If they do get in, then the fact that there are practically no failures in the treated cases (see Four groups of 10 Rh-negative men were all given three intravenous injections of 10 ml, group 0, Rh-positive whole blood at monthly intervals; 24 hours later three groups were given 1 0 ml, 0 5 ml or 0-25 ml respectively of ortho V-globulin containing 1,200 gg of anti-D per ml. Blood samples were obtained thereafter at monthly intervals for 9 months. None of the men given V-globulin produced immune anti-D, whereas 6 of the 10 untreated men did so (Pollack et Anti-D *Four cases reported by Woodrow et al. (1968) in which large amounts of Rh-positive blood had entered the circulation of Rhnegative women. In one case, where 27 ml of anti-D plasma were given, the woman developed antibodies two months later. The other 3 cases, 2 of whom were given 1,000 gg of y-globulin and one 370 ml of blood, had formed no anti-D 6-9 months later *Four cases reported by De Wit & Borst-Eilers (1968) in which large transplacental heemorrhages caused immunization in spite of the administration of anti-D, and which even suggest that enhancement may have occurred ATwo cases reported by Hughes-Jones & in which a ielatively small dose of anti-Rh failed to suppress immunization by a relatively large dose of Rh positive cells nally, fetal cells were found in 67, and as many as 25 of these had a score of more than 5. The cell counts in the vaginal and abdominal operations were rather similar. Clearly then, a considerable proportion of therapeutic abortions are liable to have a transplacental hemorrhage and when the mother is Rh negative I think she should, be treated by anti-D, since it is usually difficult to group the abortus.
HDN in the Foal
This disorder is of extreme interest and has many parallels with the Rh story in man (though the blood groups are different). Thus, the first foal is rarely affected and immunization is thought to take place by transplacental passage of cells at delivery. Unfortunately, however, the red cells of the foal are mature at birth and it is therefore not possibleto score feetal cells in the maternal circulation as it is in man. The immune antibody formed against the foal's incompatible blood is usually of the agglutinating type (Roberts 1957) , and this may be why it does not cross the placenta though it is secreted in the colostrum where for a short time it is extremely toxic. A foal born entirely normal rapidly becomes ill on suckling and may be dead within thirty-six hours. After this time the milk contains no more antibody. The disease can therefore be effectively prevented by weaning (Franks 1962) , and as this is so it is perplexing to read that the disease is of considerable economic importance in the bloodstock industry and that new methods of exchange transfusion are being devised (Cambridge Daily News, 1966, August 20) .
Possibly these differing views are representative of those often found between academics and practical men. Weaning may be easy in theory, but difficult in practice since a little colostrum may be taken, or if this is avoided, a foster mother may be hard to come by (colostrum appears to be necessary to ensure that the foal thrives). By analogy with man the disease might be preventable by giving the mare y-globulin against the incompatible antigens, but I am told that no bloodstock breeder will allow a needle within a mile of his animals. antigenicity of chemically induced tumours studied in neonatally thymectomized mice and concluded that the tumours appearing early were highly antigenic and those that had a longer latent period were less antigenic. He felt that Professor Clarke's suggestion that histocompatibility between tumour and host yvas related to degree of malignancy (or curability) was probably true, but needed a lot of experimental work to prove it.
Miss Kathleen Boonnan (Blood Transfusion Centre, Sutton) said she wished to discuss the question of ABO antibody because something was known about it which perhaps added to the puzzle. Anti-A frequently crossed the placenta from the mother to the A baby. It was known that there was often free anti-A in an A baby which was clinically quite normal. It was also known that there was anti-A attached to infant cells and that anti-A could be eluted from infant cells where the infant was clinically quite normal.
On the other hand it was known that sometimes these babies were affected with hmmolytic disease, occasionally sufficiently severe to require exchange transfusion. She had also known one or two cases where babies at post-mortem examination were shown to have kernicterus when the causative antibody appeared to be anti-A. It was a very wide problem, perhaps linked with Dr Currie's problem, as to why these destructive antibodies had got to the place where they could be destructive and yet had no ill effect. This failure to have the expected ill effect was something in which Miss Boorman was personally very interested. The relationship between the ovaries and the conceptus is of a reciprocal nature in most vertebrates. Thus, the presence of a functional corpus luteum is necessary for the survival of the early conceptus, and the removal of the ovaries before implantation interrupts pregnancy in all eutherian mammals except the armadillo. At the same time, however, there is much evidence to show that the corpus luteum of pregnancy is dependent for its continued maintenance upon the presence of the developing conceptus. Removal or destruction of the conceptus invariably leads to the involution of the corpus luteum of pregnancy.
It is with the relationship between the conceptus and the ovaries that this paper will be primarily concerned.
(1) Historical Primates: The concept that the placenta acts as an endocrine gland and is largely responsible for the striking hormonal changes that occur in the mother during pregnancy was first formulated by Halban (1904 Halban ( , 1905 . He noted from clinical observations that the endocrine readjustment associated with pregnancy occurred even in cases of ectopic pregnancy, hydatidiform mole, or where only placental tissue was present in the uterus; from these facts he concluded that a substance essential for pregnancy was secreted by the trophoblast. Within a decade both Aschner (1913), using water-soluble human placental extracts injected into guinea-pigs, and Fellner (1913) , working with immature rabbits, had produced evidence which supported the theory of a gonadotrophic principle in human placental tissue. The discovery that the blood, urine and placental tissue of pregnant women contained large amounts of gonadotrophin was made in 1927 by Aschheim & Zondek. However, these workers believed that the pituitary gland of the mother was the source of this hormone. It was left to Philipp (1929 Philipp ( , 1930 and Philipp & Huber (1936) to establish that the gonadotrophin of pregnancy was of placental origin. Perhaps the most convincing early demonstration of the ability of the human placenta to produce chorionic gonadotrophin was obtained by transplanting human chorionic villi into the anterior chamber of the eye of the rabbit (Kido 1937). Marked changes were observed in the ovaries of those host rabbits in which successful intraocular grafts had become established. These ovarian changes were identical to changes induced in control animals that had been injected with material prepared from the urine of pregnant women. Since then a large amount of confirmatory evidence from experimental -and clinical sources has been accumulated on the production of chorionic gonadotrophin by the human placenta (Rowlands & Parkes 1966) .
Results obtained by injecting human placental extracts into rabbits led Hirose (1919) to the conclusion that the maintenance of the human corpus luteum during pregnancy is dependent upon the secretion of a substance from the placenta. Murata & Adachi (1927) obtained evidence to support the conclusions of Hirose; they showed that extracts of hydatidiform mole and chorioepithelioma had the same gonadotrophic effect on the ovaries of young rabbits as extracts of normal human placental tissue.
In addition to chorionic gonadotrophin there is clear evidence to show that a number of other hormones and steroids are elaborated by the human placenta. Thus, within thirty days of conception, placental progesterone is secreted in quantities sufficient to maintain pregnancy even in the absence of the ovaries. Large quantities of (estrogen, and smaller quantities of corticosteroids and hormones such as adrenocorticotrophic hormone, prolactin and growth hormone have also been identified in the human placenta (for references see Diczfalusy & Troen 1961 , Deanesly 1966 . However, with the exception of chorionic
